Skip to main content
Journal ArticleOPEN ACCESS

Intranasal oxytocin for autism spectrum disorders (ASD)

Cochrane Database of Systematic Reviews (2017) 2017(1)
DOI: 10.1002/14651858.CD010928.pub2
1Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy of intranasal oxytocin in improving social interaction and communication deficit, and other clinical outcomes in autism spectrum disorders (ASD), and to examine its safety.

Cite

CITATION STYLE

APA

Feng, L., Wong, J. C. M., Mahendran, R., Chan, E. S. Y., & Spencer, M. D. (2017). Intranasal oxytocin for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews, 2017(1). https://doi.org/10.1002/14651858.CD010928.pub2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free